Axon Total Liab vs Deferred Long Term Liab Analysis

AXON Stock

USD 634.96 2.80 0.44%

Axon Enterprise financial indicator trend analysis is way more than just evaluating Axon Enterprise prevailing accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Axon Enterprise is a good investment. Please check the relationship between Axon Enterprise Total Liab and its Deferred Long Term Liab accounts. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Axon Enterprise. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in persons.

To learn how to invest in Axon Stock, please use our How to Invest in Axon Enterprise guide.

Total Liab vs Deferred Long Term Liab

Total Liab vs Deferred Long Term Liab Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Axon Enterprise Total Liab account and Deferred Long Term Liab. At this time, the significance of the direction appears to have very strong relationship.

The correlation between Axon Enterprise's Total Liab and Deferred Long Term Liab is 0.86. Overlapping area represents the amount of variation of Total Liab that can explain the historical movement of Deferred Long Term Liab in the same time period over historical financial statements of Axon Enterprise, assuming nothing else is changed. The correlation between historical values of Axon Enterprise's Total Liab and Deferred Long Term Liab is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Total Liab of Axon Enterprise are associated (or correlated) with its Deferred Long Term Liab. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Deferred Long Term Liab has no effect on the direction of Total Liab i.e., Axon Enterprise's Total Liab and Deferred Long Term Liab go up and down completely randomly.

Correlation Coefficient

0.86

Relationship Direction	Positive
Relationship Strength	Strong

View All Relationships

Total Liab

The total amount of all liabilities that a company has, including both short-term and long-term liabilities.

Deferred Long Term Liab

Liabilities that are due after more than one year, including deferred tax liabilities and deferred revenue.

Most indicators from Axon Enterprise's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Axon Enterprise current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Axon Enterprise. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in persons.

To learn how to invest in Axon Stock, please use our How to Invest in Axon Enterprise guide.At this time, Axon Enterprise's Selling General Administrative is very stable compared to the past year. As of the 28th of November 2024, Issuance Of Capital Stock is likely to grow to about 167.6 M, though Tax Provision is likely to grow to (11.6 M).

	2021	2022	2023	2024 (projected)
Interest Expense	26.7M	103.3M	7.0M	7.1M
Depreciation And Amortization	24.3M	31.1M	32.6M	34.3M

Interest Expense Depreciation And Amortization

Axon Enterprise fundamental ratios Correlations

	Total Assets	Short Long Term Debt Total	Other Current Liab	Total Current Liabilities	Total Stockholder Equity	Property Plant And Equipment Net	Current Deferred Revenue	Net Debt	Retained Earnings	Accounts Payable	Cash	Non Current Assets Total	Long Term Debt	Cash And Short Term Investments	Net Receivables	Common Stock Total Equity	Common Stock Shares Outstanding	Non Current Liabilities Total	Inventory	Other Current Assets	Other Stockholder Equity	Total Liab	Property Plant And Equipment Gross	Total Current Assets	Treasury Stock	Short Term Debt
Total Assets		0.93	0.77	1.0	0.98	0.99	1.0	0.46	0.93	0.99	0.94	0.99	0.79	0.99	0.99	0.29	0.73	0.97	0.99	0.98	0.97	0.99	0.97	1.0	-0.45	0.11
Short Long Term Debt Total	0.93		0.67	0.92	0.85	0.9	0.91	0.72	0.88	0.94	0.83	0.94	0.56	0.93	0.87	0.16	0.61	0.99	0.95	0.9	0.81	0.97	0.89	0.92	-0.26	-0.24
Other Current Liab	0.77	0.67		0.75	0.79	0.77	0.76	0.38	0.52	0.67	0.63	0.83	0.68	0.7	0.81	0.25	0.66	0.72	0.73	0.69	0.84	0.74	0.64	0.74	-0.41	0.36
Total Current Liabilities	1.0	0.92	0.75		0.98	0.99	1.0	0.42	0.93	0.99	0.95	0.99	0.77	0.98	0.99	0.28	0.71	0.96	0.99	0.99	0.96	0.99	0.97	1.0	-0.45	0.13
Total Stockholder Equity	0.98	0.85	0.79	0.98		0.98	0.98	0.32	0.9	0.95	0.93	0.97	0.86	0.97	0.99	0.33	0.75	0.91	0.96	0.97	0.99	0.95	0.95	0.99	-0.5	0.26
Property Plant And Equipment Net	0.99	0.9	0.77	0.99	0.98		0.99	0.41	0.91	0.97	0.93	0.98	0.75	0.97	0.99	0.28	0.73	0.94	0.99	0.98	0.97	0.97	0.98	0.99	-0.42	0.15
Current Deferred Revenue	1.0	0.91	0.76	1.0	0.98	0.99		0.41	0.93	0.98	0.95	0.99	0.79	0.98	0.99	0.29	0.72	0.95	0.99	0.99	0.96	0.98	0.97	0.99	-0.46	0.16
Net Debt	0.46	0.72	0.38	0.42	0.32	0.41	0.41		0.39	0.48	0.2	0.51	-0.04	0.45	0.35	-0.12	0.21	0.64	0.51	0.37	0.29	0.56	0.41	0.43	0.15	-0.67
Retained Earnings	0.93	0.88	0.52	0.93	0.9	0.91	0.93	0.39		0.96	0.92	0.89	0.72	0.96	0.88	0.4	0.68	0.91	0.94	0.95	0.85	0.93	0.94	0.94	-0.53	-0.01
Accounts Payable	0.99	0.94	0.67	0.99	0.95	0.97	0.98	0.48	0.96		0.94	0.97	0.73	0.99	0.96	0.27	0.69	0.97	0.99	0.99	0.92	0.99	0.98	0.99	-0.4	0.01
Cash	0.94	0.83	0.63	0.95	0.93	0.93	0.95	0.2	0.92	0.94		0.91	0.82	0.94	0.94	0.32	0.69	0.88	0.92	0.96	0.91	0.92	0.92	0.95	-0.48	0.21
Non Current Assets Total	0.99	0.94	0.83	0.99	0.97	0.98	0.99	0.51	0.89	0.97	0.91		0.76	0.97	0.98	0.28	0.73	0.97	0.98	0.96	0.96	0.99	0.94	0.98	-0.44	0.11
Long Term Debt	0.79	0.56	0.68	0.77	0.86	0.75	0.79	-0.04	0.72	0.73	0.82	0.76		0.79	0.82	0.35	0.66	0.64	0.7	0.78	0.87	0.71	0.7	0.79	-0.59	0.55
Cash And Short Term Investments	0.99	0.93	0.7	0.98	0.97	0.97	0.98	0.45	0.96	0.99	0.94	0.97	0.79		0.96	0.28	0.7	0.96	0.98	0.98	0.95	0.98	0.97	1.0	-0.43	0.06
Net Receivables	0.99	0.87	0.81	0.99	0.99	0.99	0.99	0.35	0.88	0.96	0.94	0.98	0.82	0.96		0.29	0.73	0.92	0.97	0.98	0.99	0.96	0.95	0.98	-0.46	0.25
Common Stock Total Equity	0.29	0.16	0.25	0.28	0.33	0.28	0.29	-0.12	0.4	0.27	0.32	0.28	0.35	0.28	0.29		0.74	0.21	0.27	0.3	0.29	0.24	0.24	0.29	-0.86	0.3
Common Stock Shares Outstanding	0.73	0.61	0.66	0.71	0.75	0.73	0.72	0.21	0.68	0.69	0.69	0.73	0.66	0.7	0.73	0.74		0.66	0.69	0.72	0.74	0.69	0.67	0.72	-0.67	0.27
Non Current Liabilities Total	0.97	0.99	0.72	0.96	0.91	0.94	0.95	0.64	0.91	0.97	0.88	0.97	0.64	0.96	0.92	0.21	0.66		0.98	0.94	0.87	0.99	0.93	0.96	-0.33	-0.12
Inventory	0.99	0.95	0.73	0.99	0.96	0.99	0.99	0.51	0.94	0.99	0.92	0.98	0.7	0.98	0.97	0.27	0.69	0.98		0.98	0.93	0.99	0.98	0.99	-0.41	0.03
Other Current Assets	0.98	0.9	0.69	0.99	0.97	0.98	0.99	0.37	0.95	0.99	0.96	0.96	0.78	0.98	0.98	0.3	0.72	0.94	0.98		0.94	0.97	0.98	0.99	-0.46	0.14
Other Stockholder Equity	0.97	0.81	0.84	0.96	0.99	0.97	0.96	0.29	0.85	0.92	0.91	0.96	0.87	0.95	0.99	0.29	0.74	0.87	0.93	0.94		0.92	0.93	0.96	-0.48	0.33
Total Liab	0.99	0.97	0.74	0.99	0.95	0.97	0.98	0.56	0.93	0.99	0.92	0.99	0.71	0.98	0.96	0.24	0.69	0.99	0.99	0.97	0.92		0.96	0.98	-0.38	-0.02
Property Plant And Equipment Gross	0.97	0.89	0.64	0.97	0.95	0.98	0.97	0.41	0.94	0.98	0.92	0.94	0.7	0.97	0.95	0.24	0.67	0.93	0.98	0.98	0.93	0.96		0.98	-0.36	0.06
Total Current Assets	1.0	0.92	0.74	1.0	0.99	0.99	0.99	0.43	0.94	0.99	0.95	0.98	0.79	1.0	0.98	0.29	0.72	0.96	0.99	0.99	0.96	0.98	0.98		-0.44	0.12
Treasury Stock	-0.45	-0.26	-0.41	-0.45	-0.5	-0.42	-0.46	0.15	-0.53	-0.4	-0.48	-0.44	-0.59	-0.43	-0.46	-0.86	-0.67	-0.33	-0.41	-0.46	-0.48	-0.38	-0.36	-0.44		-0.5
Short Term Debt	0.11	-0.24	0.36	0.13	0.26	0.15	0.16	-0.67	-0.01	0.01	0.21	0.11	0.55	0.06	0.25	0.3	0.27	-0.12	0.03	0.14	0.33	-0.02	0.06	0.12	-0.5

Click cells to compare fundamentals

Axon Enterprise Account Relationship Matchups

Axon Enterprise fundamental ratios Accounts

	2019	2020	2021	2022	2023	2024 (projected)
Total Assets	845.6M	1.4B	1.7B	2.9B	3.4B	3.6B
Other Current Liab	3.9M	228.3M	382.6M	522.8M	214.2M	224.9M
Total Current Liabilities	195.6M	256.3M	418.5M	602.6M	800.0M	840.0M
Total Stockholder Equity	543.5M	976.3M	1.0B	1.3B	1.6B	1.7B
Property Plant And Equipment Net	43.8M	105.5M	138.5M	169.8M	236.7M	248.5M
Current Deferred Revenue	120.8M	166.9M	276.1M	380.4M	491.7M	516.3M
Net Debt	(161.6M)	(131.1M)	(329.4M)	357.4M	112.1M	117.7M
Retained Earnings	172.3M	169.9M	109.9M	257.0M	431.2M	452.8M
Accounts Payable	25.9M	24.1M	32.2M	59.9M	88.3M	92.7M
Cash	172.3M	155.4M	356.3M	353.7M	598.5M	628.5M
Non Current Assets Total	226.5M	399.1M	578.7M	1.0B	1.0B	1.1B
Cash And Short Term Investments	350.8M	562.0M	443.0M	974.7M	1.3B	1.4B
Net Receivables	194.6M	293.1M	501.2M	555.1M	693.5M	728.1M
Common Stock Shares Outstanding	60.0M	61.8M	66.2M	72.5M	75.5M	62.8M
Liabilities And Stockholders Equity	845.6M	1.4B	1.7B	2.9B	3.4B	3.6B
Non Current Liabilities Total	106.6M	148.4M	221.8M	980.8M	1.0B	1.1B
Inventory	38.8M	90.0M	108.7M	202.5M	269.9M	283.3M
Other Current Assets	34.9M	36.9M	56.5M	73.0M	112.8M	118.4M
Other Stockholder Equity	372.3M	806.2M	939.3M	1.0B	1.2B	1.3B
Total Liab	302.1M	404.8M	640.4M	1.6B	1.8B	1.9B
Property Plant And Equipment Gross	53.4M	127.8M	138.5M	169.8M	341.9M	359.0M
Total Current Assets	619.1M	982.0M	1.1B	1.8B	2.4B	2.5B
Accumulated Other Comprehensive Income	(1.1M)	141K	(1.3M)	(7.2M)	(10.7M)	(10.1M)
Short Term Debt	45.0M	59.8M	103.7M	6.4M	5.8M	5.5M
Property Plant Equipment	43.8M	105.5M	138.5M	208.2M	239.4M	251.4M
Non Currrent Assets Other	71.8M	122.5M	139.3M	210.0M	264.8M	278.0M
Intangible Assets	12.8M	9.4M	15.5M	12.2M	19.5M	20.5M
Other Assets	89.8M	258.9M	266.4M	328.5M	1.0	0.95
Other Liab	99.8M	148.4M	221.8M	269.6M	310.1M	325.6M
Short Term Investments	178.5M	406.5M	86.7M	621.0M	722.0M	758.1M
Net Tangible Assets	505.7M	941.6M	988.8M	1.2B	1.4B	1.5B
Good Will	25.0M	25.2M	43.6M	45.0M	57.9M	60.8M
Retained Earnings Total Equity	171.4M	172.3M	169.9M	109.9M	126.4M	117.9M
Capital Surpluse	453.4M	528.3M	962.2M	1.1B	1.3B	1.3B
Deferred Long Term Liab	8.1M	5.4M	6.5M	96.3M	110.7M	116.2M

Pair Trading with Axon Enterprise

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Axon Enterprise position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Axon Enterprise will appreciate offsetting losses from the drop in the long position's value.

Moving together with Axon Stock

0.83

Curtiss Wright

Pair Corr

Moving against Axon Stock

0.7	BA	Boeing Fiscal Year End 29th of January 2025	Pair Corr
0.49	EVTL	Vertical Aerospace Trending	Pair Corr
0.35	GD	General Dynamics Fiscal Year End 22nd of January 2025	Pair Corr

The ability to find closely correlated positions to Axon Enterprise could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Axon Enterprise when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Axon Enterprise - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Axon Enterprise to buy it.

The correlation of Axon Enterprise is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Axon Enterprise moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Axon Enterprise moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.

Correlation analysis and pair trading evaluation for Axon Enterprise can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.

Pair Correlation Correlation Matching

When determining whether Axon Enterprise offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Axon Enterprise's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Axon Enterprise Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Axon Enterprise Stock:

How To Invest In Axon

Details

Is Axon Stock a good investment?

Details

What is Axon Enterprise's Net Worth?

Details

Largest Aerospace & Defense Companies

View

Largest Industrials Companies

View

Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Axon Enterprise. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in persons.

To learn how to invest in Axon Stock, please use our How to Invest in Axon Enterprise guide.

You can also try the Transaction History module to view history of all your transactions and understand their impact on performance.

Is Aerospace & Defense space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Axon Enterprise. If investors know Axon will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Axon Enterprise listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

Quarterly Earnings Growth

0.062

Earnings Share

3.87

Revenue Per Share

25.727

Quarterly Revenue Growth

0.317

Return On Assets

0.0229

The market value of Axon Enterprise is measured differently than its book value, which is the value of Axon that is recorded on the company's balance sheet. Investors also form their own opinion of Axon Enterprise's value that differs from its market value or its book value, called intrinsic value, which is Axon Enterprise's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Axon Enterprise's market value can be influenced by many factors that don't directly affect Axon Enterprise's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between Axon Enterprise's value and its price as these two are different measures arrived at by different means. Investors typically determine if Axon Enterprise is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Axon Enterprise's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Axon Total Liab vs Deferred Long Term Liab Analysis

Total Liab vs Deferred Long Term Liab

Total Liab vs Deferred Long Term Liab Correlation Analysis

Correlation Coefficient

Total Liab

Deferred Long Term Liab

Axon Enterprise fundamental ratios Correlations

Axon Enterprise Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Axon Enterprise fundamental ratios Accounts

Pair Trading with Axon Enterprise

Moving together with Axon Stock

Moving against Axon Stock

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Total Current Liabilities	+ 1.0	Total Assets
Current Deferred Revenue	+ 1.0	Total Assets
Total Current Assets	+ 1.0	Total Assets
Current Deferred Revenue	+ 1.0	Total Current Liabilities
Total Current Assets	+ 1.0	Total Current Liabilities
Total Current Assets	+ 1.0	Cash And Short Term Investments

Treasury Stock	- 0.86	Common Stock Total Equity
Treasury Stock	- 0.67	Common Stock Shares Outstanding
Short Term Debt	- 0.67	Net Debt
Treasury Stock	- 0.59	Long Term Debt
Treasury Stock	- 0.53	Retained Earnings
Short Term Debt	- 0.5	Treasury Stock